Related Experiment Video
Updated: Mar 29, 2026

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
7.1K
Efficacy and implementation of an Internet psychoeducational program for teens with type 1 diabetes
Robin Whittemore1, Lauren S Liberti2, Sangchoon Jeon2
1Yale University School of Nursing, Orange, CT, USA. robin.whittemore@yale.edu.
Pediatric Diabetes
|November 28, 2015
Summary
Low participation in an internet psychoeducational program for teens with type 1 diabetes may limit health benefits. Frequent reminders and family support could improve engagement and outcomes.
Area of Science:
- Pediatric Endocrinology
- Digital Health Interventions
- Behavioral Science
Background:
- Type 1 diabetes (T1D) management in adolescents presents unique challenges.
- Internet-based interventions offer potential for improved engagement and health outcomes.
- Existing psychoeducational programs require evaluation for efficacy and participation.
Purpose of the Study:
- To assess participation and preliminary efficacy of the Teens.Connect internet psychoeducational program.
- To compare Teens.Connect with an open-access diabetes website (Planet D).
- To evaluate effects on A1C, quality of life (QoL), and psychosocial/behavioral factors.
Main Methods:
- 124 adolescents (11-14 years) with T1D were randomized to Teens.Connect or Planet D.
- Data collected at baseline, 3, and 6 months, including A1C from clinic records.
- Participation metrics: log-ins, discussion posts, lessons completed; analyses used descriptive and mixed models.
Main Results:
- 85% registered; satisfaction and log-ins were similar between groups.
- Planet D had higher discussion forum participation (28 vs. 19 posts/teen).
- Teens.Connect lesson completion was low (69%); no significant differences in A1C or QoL at 6 months, but lower perceived stress in Teens.Connect group.
Conclusions:
- Low active participation in Teens.Connect, potentially due to insufficient reminders, may have hindered treatment effects.
- Adolescents face competing demands impacting program engagement.
- Strategic implementation with reminders and family support is crucial for participation and improved health outcomes.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K

